Arcutis Biotherapeutics Inc — Balance Sheet (NASDAQ:ARQT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 298.27 M408.15 M449.27 M341.37 M348.89 M432.97 M Total liabilities 27.65 M110.47 M239.69 M252.7 M191.35 M243.49 M Total equity 270.62 M297.68 M209.58 M88.67 M157.54 M189.48 M Total liabilities & shareholders' equities 298.27 M408.15 M449.27 M341.37 M348.89 M432.97 M Total debt 4.96 M72.35 M197.77 M201.8 M107.2 M108.96 M Net debt -279.48 M-314.71 M-211.82 M-70.06 M-120.75 M-112.02 M

News

Arcutis Biotherapeutics Shows Market Leadership With Jump To 82 RS Rating

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

Arcutis reports long-term data on eczema cream for young children

Arcutis enrolls first patient in ARQ-234 atopic dermatitis trial

Arcutis at TD Cowen Conference: Strategic Growth Insights

Mizuho cuts Arcutis stock price target to $35 on higher costs

Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists

Stock Market Can't Hold Key Levels Amid AI Concerns; Nvidia Tumbles Despite Strong Earnings: Weekly Review

Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More

Needham raises Arcutis stock price target to $36 on strong sales

H.C. Wainwright raises Arcutis stock price target on strong Zoryve sales

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates